Bank of America
PYXS icon

Bank of America’s Pyxis Oncology PYXS Stock Holding History

Bank of America’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$242K Buy
80,464
+63,657
+379% +$122K ﹤0.01% 5303
2026
Q1 		$24.5K Sell
16,807
-571,044
-97% -$861K ﹤0.01% 5641
2025
Q4 		$676K Sell
587,851
-28,071
-5% -$99K ﹤0.01% 4743
2025
Q3 		$1.37M Buy
615,922
+593,853
+2,691% +$855K ﹤0.01% 5120
2025
Q2 		$24.3K Sell
22,069
-18,254
-45% -$20.6K ﹤0.01% 7012
2025
Q1 		$39.5K Sell
40,323
-13,422
-25% -$17.9K ﹤0.01% 6809
2024
Q4 		$83.8K Buy
53,745
+9,062
+20% +$26.1K ﹤0.01% 6469
2024
Q3 		$164K Sell
44,683
-99
-0.2% -$346 ﹤0.01% 6107
2024
Q2 		$148K Buy
44,782
+15,069
+51% +$63.4K ﹤0.01% 6051
2024
Q1 		$127K Buy
29,713
+9,869
+50% +$41.5K ﹤0.01% 6126
2023
Q4 		$35.7K Sell
19,844
-81,010
-80% -$139K ﹤0.01% 6680
2023
Q3 		$201K Sell
100,854
-29,829
-23% -$69.1K ﹤0.01% 5899
2023
Q2 		$335K Buy
130,683
+107,191
+456% +$340K ﹤0.01% 5520
2023
Q1 		$94.2K Sell
23,492
-40,103
-63% -$80.1K ﹤0.01% 6278
2022
Q4 		$85.2K Buy
63,595
+43,510
+217% +$65.3K ﹤0.01% 6289
2022
Q3 		$40K Buy
20,085
+4,353
+28% +$11.4K ﹤0.01% 6767
2022
Q2 		$37K Sell
15,732
-4,546
-22% -$12.1K ﹤0.01% 6970
2022
Q1 		$82K Sell
20,278
-8,338
-29% -$60.9K ﹤0.01% 6959
2021
Q4 		$314K Buy
+28,616
New +$328K ﹤0.01% 6211

Other funds holding PYXS

GGI
GordonMD Global Investments Beverely Hills, California $207M AUM
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America's PYXS Position: Q2 2026 in Review

Bank of America increased its Pyxis Oncology (PYXS) stake by 379% in Q2 2026, buying an estimated $122K and bringing the position to 80,464 shares worth $242K. The position accounts for ﹤0.01% of the portfolio, ranked #5303.

Bank of America first reported a position in PYXS in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.37M in Q3 2025. 76 funds tracked by Wall St. Rank hold PYXS as of Q2 2026.

  • Bank of America held 80,464 shares of Pyxis Oncology worth $242K as of Q2 2026.
  • Bank of America bought 63,657 Pyxis Oncology shares in Q2 2026, an estimated $122K.
  • Pyxis Oncology made up ﹤0.01% of Bank of America's portfolio in Q2 2026, its #5303 holding.
  • Bank of America first reported a position in Pyxis Oncology in Q4 2021 and has held it in 19 quarters since.
  • Bank of America's Pyxis Oncology position peaked at $1.37M in Q3 2025.
  • 76 funds tracked by Wall St. Rank held Pyxis Oncology as of Q2 2026.

Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.